Prepared by: Dante Fichera
FREE Q2 2004 Life Sciences Venture Capital Study available at: CapitalHunter.com.
Venture capital activity has bounced back up this reporting period increasing by 164% over the prior period. $401 million in venture capital was invested in 35 companies during the period.
In addition, eight companies began trading on Wall Street with over $2.4 billion raised in equity through IPOs. The eight IPO’s this reporting period are as follows:
1. Domino’s Pizza for $336.7 million
2. Home Banc Mortgage for $225 million
3. Phase Forward for $39.4 million
4. Greenfield Online for $58 million
5. Freescale Semiconductor for $1.58 billion
6. QC Holdings for $70 million
7. Collegiate Funding Services for $150 million
8. Xenogen for $29.4 million
|
 |
CapitalHunter.com identified that $401 million of venture capital was invested in 35 U.S.-based companies during this week’s reporting period. The average deal size was approximately $11.46 million. The amount of venture capital invested this period increased by 164% over last week’s $152 million.
What’s Hot: California, Software, and Series B. |
|
|
 |
Geographically,14 California companies raised $179.1 million in venture financings. The largest venture financing in California this period went into SkinMedica for $30 million. Skinmedica is a Carlsbad is a company that focuses on the treatment of skin conditions and currently markets a full line of cosmeceutical products sold only though physicians. |
|
|
 |
The software sector raised a little over 21% of the venture capital this period. Ten software companies raised over $89 million in venture financing. |
|
|
 |
Companies raising their Series B round of financing led this week’s venture capital activity. Series B companies represented 36% of the total venture capital deployed this period. The largest Series B financing was into Trubion Pharmaceuticals. Trubion Pharmaceuticals raised $32 million and is a biopharmaceutical company that focuses on the discovery, development and commercialization of novel medicines to treat inflammatory disease and cancer.
To learn more about the equity financings of this week please visit www.capitalhunter.com and obtain a free trial subscription to our service – no obligation. |
|
|
 |
|
The three largest venture deals this period are as follows: |
| |
Company |
Industry |
Investment |
| 1 |
Trubion Pharmaceuticals |
Biotechnology |
$32 million |
| 2 |
SKinMedica |
Biotechnology |
$30 million |
| 3 |
MaginK Display Technologies |
Electronics |
$27 million |
|
 |
The following fifteen investors funded the above mentioned top three venture capital investments for over $89 million: |
| 1 | Apax Partners | | 2 | ARCH Venture Partners | | 3 | ATP Capital | | 4 | Domain Associates | | 5 | Formula Ventures of Israel | | 6 | Frazier Healthcare Investments | | 7 | HealthCare Ventures | | 8 | Japan Asia Investment | | 9 | Montreux Equity Partners | | 10 | Oxford Bioscience Partners | | 11 | Perseus Soros BioPharmaceutical Fund | | 12 | Prospect Venture Partners | | 13 | St. Paul Venture Capital | | 14 | VantagePoint Venture Partners | | 15 | Venrock Associates |
|
A total of 73 worldwide equity financings of private and public companies occurred during this reporting period. Each of the 73 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s. Also available is access to over 30,000 other historic equity financings through theCapitalHunter.com searchable database.
About CapitalHunter.com
CapitalHunter.com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter.com searchable database to research newly and historic financings and to identify active investors.
Please visit www.capitalhunter.com and get immediate access for free for a two week trial period. New subscribers can request a free investor analysis. |
|
|
|
©2003 Capital Hunter, Inc. all rights reserved
|
To be REMOVED from this free service, CLICK HERE |